Buy Neogen Chemicals Ltd For Target Rs.1515 - ICICI Direct
Custom synthesis offers strong visibility ahead…
About the stock: Commencing operations in 1991, Neogen Chemicals manufactures specialty organic bromine-based chemical compounds as well as specialty inorganic lithium-based chemicals compounds.
* The company’s products find application in pharmaceutical intermediates, agrochemical intermediates, engineering fluids, polymers additives and water treatment chemicals to name a few
* Neogen has two segments viz. (i) organic chemicals, (ii) inorganic chemicals of which organic chemical constitute ~80% of overall revenue while the rest comes from inorganic chemicals
Phase 1 Dahej plant commissioned:
* The company incurred a capex of | 75 crore for Phase 1 at Dahej while the same for Phase 2 remains at | 55 crore. The phase 1 capacity would largely cater to the custom synthesis business while the same for phase 2 is expected to be for advanced intermediates
* The asset turn is expected to be around ~2.7x, which provides incremental revenue visibility of ~| 350 crore. Since both these business verticals are margin accretive thus, incremental revenue share from both segments is expected to aid gross margins and thereby OPM
* This should inch up return ratios and thereby valuations in medium term
What should investors do?
The stock appreciated at 80% CAGR in last two years.
* We retain BUY rating on the back of better growth outlook of the custom synthesis business
Target Price and Valuation: We value Neogen Chemicals at 40x P/E FY24E EPS to arrive at a revised target price of | 1515/share (earlier | 1095/share).
Key triggers for future price performance:
* Phase 1 and Phase 2 capex at Dahej bodes well for advance intermediates and custom synthesis revenue growth
* Higher share of value added business portfolio is expected to improve the margin profile of the business
* Allocation of incremental FCF towards organic/inorganic growth likely to expand return ratios further.
Alternate Stock Idea: Apart from Neogen Chemicals, in our chemical coverage we also like Sumitomo Chemicals.
* Trigger for Sumitomo Chemical’s future revenue growth would be increasing CRAMS opportunity from SCC Japan and Nufarm
* BUY with a target price of | 505
To Read Complete Report & Disclaimer Click Here
https://secure.icicidirect.com/Content/StaticData/Disclaimer.html
Above views are of the author and not of the website kindly read disclaimer
 2.jpg)
